150 related articles for article (PubMed ID: 9222074)
1. Pharmacokinetics and safety of trovafloxacin in healthy male volunteers following administration of single intravenous doses of the prodrug, alatrofloxacin.
Vincent J; Venitz J; Teng R; Baris BA; Willavize SA; Polzer RJ; Friedman HL
J Antimicrob Chemother; 1997 Jun; 39 Suppl B():75-80. PubMed ID: 9222074
[TBL] [Abstract][Full Text] [Related]
2. Single- and multiple-dose administration, dosing regimens, and pharmacokinetics of trovafloxacin and alatrofloxacin in humans.
Vincent J; Dogolo L; Baris BA; Willavize SA; Teng R
Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):427-30. PubMed ID: 9758287
[TBL] [Abstract][Full Text] [Related]
3. Oral bioavailability of trovafloxacin with and without food in healthy volunteers.
Teng R; Dogolo LC; Willavize SA; Friedman HL; Vincent J
J Antimicrob Chemother; 1997 Jun; 39 Suppl B():87-92. PubMed ID: 9222076
[TBL] [Abstract][Full Text] [Related]
4. Penetration of trovafloxacin into cerebrospinal fluid in humans following intravenous infusion of alatrofloxacin.
Cutler NR; Vincent J; Jhee SS; Teng R; Wardle T; Lucas G; Dogolo LC; Sramek JJ
Antimicrob Agents Chemother; 1997 Jun; 41(6):1298-300. PubMed ID: 9174187
[TBL] [Abstract][Full Text] [Related]
5. Safety and tolerability of intravenous-to-oral treatment and single-dose intravenous or oral prophylaxis with trovafloxacin.
Williams DJ; Hopkins S
Am J Surg; 1998 Dec; 176(6A Suppl):74S-79S. PubMed ID: 9935261
[TBL] [Abstract][Full Text] [Related]
6. Concentrations of trovafloxacin in colonic tissue and peritoneal fluid after intravenous infusion of the prodrug alatrofloxacin in patients undergoing colorectal surgery.
Melnik G; Schwesinger WH; Dogolo LC; Teng R; Vincent J
Am J Surg; 1998 Dec; 176(6A Suppl):14S-17S. PubMed ID: 9935251
[TBL] [Abstract][Full Text] [Related]
7. Oral bioavailability and pharmacokinetics of trovafloxacin in patients with AIDS.
Lacy MK; Nicolau DP; Nightingale CH; Geffken A; Teng R; Vincent J; Quintiliani R
Antimicrob Agents Chemother; 1999 Dec; 43(12):3005-7. PubMed ID: 10582898
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and metabolism of single oral doses of trovafloxacin.
Vincent J; Teng R; Dalvie DK; Friedman HL
Am J Surg; 1998 Dec; 176(6A Suppl):8S-13S. PubMed ID: 9935250
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of a fluoronaphthyridone, trovafloxacin (CP 99,219), in infants and children following administration of a single intravenous dose of alatrofloxacin.
Bradley JS; Kearns GL; Reed MD; Capparelli EV; Vincent J
Antimicrob Agents Chemother; 2000 May; 44(5):1195-9. PubMed ID: 10770751
[TBL] [Abstract][Full Text] [Related]
10. Hepatobiliary elimination of trovafloxacin and metabolites following single oral doses in healthy volunteers.
Melnik G; Schwesinger WH; Teng R; Dogolo LC; Vincent J
Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):424-6. PubMed ID: 9758286
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and safety of trovafloxacin (CP-99,219), a new quinolone antibiotic, following administration of single oral doses to healthy male volunteers.
Teng R; Harris SC; Nix DE; Schentag JJ; Foulds G; Liston TE
J Antimicrob Chemother; 1995 Aug; 36(2):385-94. PubMed ID: 8522468
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of intravenous trovafloxacin in critically ill adults.
Olsen KM; Rebuck JA; Weidenbach T; Fish DN
Pharmacotherapy; 2000 Apr; 20(4):400-4. PubMed ID: 10772370
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of trovafloxacin (CP-99,219), a new quinolone, in rats, dogs, and monkeys.
Teng R; Girard D; Gootz TD; Foulds G; Liston TE
Antimicrob Agents Chemother; 1996 Mar; 40(3):561-6. PubMed ID: 8851571
[TBL] [Abstract][Full Text] [Related]
14. Multiple-dose pharmacokinetics and safety of trovafloxacin in healthy volunteers.
Teng R; Liston TE; Harris SC
J Antimicrob Chemother; 1996 May; 37(5):955-63. PubMed ID: 8737145
[TBL] [Abstract][Full Text] [Related]
15. Double-blind comparison of single-dose alatrofloxacin and cefotetan as prophylaxis of infection following elective colorectal surgery. Trovafloxacin Surgical Group.
Milsom JW; Smith DL; Corman ML; Howerton RA; Yellin AE; Luke DR
Am J Surg; 1998 Dec; 176(6A Suppl):46S-52S. PubMed ID: 9935257
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and penetration into inflammatory fluid of trovafloxacin (CP-99,219).
Wise R; Mortiboy D; Child J; Andrews JM
Antimicrob Agents Chemother; 1996 Jan; 40(1):47-9. PubMed ID: 8787877
[TBL] [Abstract][Full Text] [Related]
17. The pharmacokinetic effects of coadministration of morphine and trovafloxacin in healthy subjects.
Vincent J; Hunt T; Teng R; Robarge L; Willavize SA; Friedman HL
Am J Surg; 1998 Dec; 176(6A Suppl):32S-38S. PubMed ID: 9935255
[TBL] [Abstract][Full Text] [Related]
18. Excretion and metabolism of trovafloxacin in humans.
Dalvie DK; Khosla N; Vincent J
Drug Metab Dispos; 1997 Apr; 25(4):423-7. PubMed ID: 9107540
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial properties of gemifloxacin and trovafloxacin in urine ex vivo: phase I study.
García-Calvo G; Parra A; Aguilar L; Ponte C; Giménez MJ; Carcas A; Kinzig-Schippers M; Soriano F
Antimicrob Agents Chemother; 2001 Jun; 45(6):1876-8. PubMed ID: 11353641
[TBL] [Abstract][Full Text] [Related]
20. Trovafloxacin in the treatment of intra-abdominal infections: results of a double-blind, multicenter comparison with imipenem/cilastatin. Trovafloxacin Surgical Group.
Donahue PE; Smith DL; Yellin AE; Mintz SJ; Bur F; Luke DR
Am J Surg; 1998 Dec; 176(6A Suppl):53S-61S. PubMed ID: 9935258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
